R2 relaxometry based MR imaging for estimation of liver iron content: A comparison between two methods
- 93 Downloads
To compare the reproducibility and accuracy of R2-relaxometry MRI for estimation of liver iron concentration (LIC) between in-house analysis and FDA-approved commercially available third party results.
All MR studies were performed on a 1.5T scanner. Multi-echo spin-echo scans with a fixed TR and increasing TE values of 6 ms, 9 ms, 12 ms, 15 ms, and 18 ms (spaced at 3 ms intervals) were used. Post-processing of the images to calculate mean relaxivity, R2, included drawing of regions of interest to include the whole liver on mid-slice. The relationship between liver R2 values and estimated LIC calculated with in-house analysis and values reported by an external company (FerriScan®, Resonance Health, Australia) were assessed with correlation coefficients and Bland–Altman difference plots. Continuous variables are presented as mean ± standard deviation. Significance was set at p value < 0.05.
474 studies from 175 patients were included in the study (mean age 10.4 ± 4.2 years (range 1–18 years); 254 studies from girls, 220 studies from boys). LIC ranged from 0.6 to 43 mg/g dry tissue, covering a broad range from normal levels to extremely high iron levels. Linearity between proprietary and in-house methods was excellent across the observed range for R2 (31.5 to 334.8 s−1); showing a correlation coefficient of r = 0.87, p < 0.001. Bland–Altman R2 difference plot between the two methods shows a mean bias of + 21.5 s−1 (range − 47.0 to + 90.0 s−1 between two standard deviations). LIC reported by FerriScan® compared with LIC estimated in-house with R2 as reported by FerriScan® agreed strongly, (r = 1.0, p < 0.001).
R2 relaxometry MR imaging for liver iron concentration estimation is reproducible between proprietary FDA-approved commercial software and in-house analysis methods.
KeywordsLiver iron Pediatric Magnetic resonance imaging LIC R2
- 1.Lieu PT, Heiskala M Fau - Peterson PA, Peterson Pa Fau - Yang Y, Yang Y. The roles of iron in health and disease. (0098-2997 (Print)).Google Scholar
- 6.Cunha GM, Glaser KJ, Bergman A, Luz RP, de Figueiredo EH, Lobo Lopes FPP. Feasibility and agreement of stiffness measurements using gradient-echo and spin-echo MR elastography sequences in unselected patients undergoing liver MRI. The British journal of radiology. 2018;91(1087):20180126.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology (Baltimore, Md). 2000;32(3):477-81.Google Scholar
- 13.Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci. 1993;38(8):1480-4.Google Scholar
- 20.Dixon RM, Styles P, al-Refaie FN, Kemp GJ, Donohue SM, Wonke B, et al. Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy. Hepatology (Baltimore, Md). 1994;19(4):904-10.Google Scholar
- 23.Mavrogeni SI, Gotsis ED, Markussis V, Tsekos N, Politis C, Vretou E, et al. T2 relaxation time study of iron overload in b-thalassemia. Magma (New York, NY). 1998;6(1):7-12.Google Scholar
- 24.Papakonstantinou O, Kostaridou S, Maris T, Gouliamos A, Premetis E, Kouloulias V, et al. Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. Journal of pediatric hematology/oncology. 1999;21(2):142-8.CrossRefPubMedGoogle Scholar
- 29.Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magnetic resonance imaging clinics of North America. 2010;18(3):359-81, ix.Google Scholar
- 31.Serai SD, Trout AT, Fleck RJ, Quinn CT, Dillman JR. Measuring liver T2* and cardiac T2* in a single acquisition. Abdom Radiol (NY). 2018.Google Scholar